HER2 staining of breast cancer is reduced under the current protocol of Ventana PATHWAY anti‐HER‐2/neu (4B5)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HER2 staining of breast cancer is reduced under the current protocol of Ventana PATHWAY anti‐HER‐2/neu (4B5)

Published:2024-01-10 Issue:2 Volume:74 Page:99-101
ISSN:1320-5463
Container-title:Pathology International
language:en
Short-container-title:Pathology International

Author:

Horimoto Yoshiya¹²³^ORCID,Onagi Hiroko¹,Watanabe Junichiro²,Hayashi Takuo¹⁴^ORCID

Affiliation:

1. Department of Human Pathology, Faculty of Medicine Juntendo University Tokyo Japan

2. Department of Breast Oncology, Faculty of Medicine Juntendo University Tokyo Japan

3. Department of Breast Surgery and Oncology Tokyo Medical University Tokyo Japan

4. Department of Diagnostic Pathology Juntendo University Hospital Tokyo Japan

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pin.13404

Reference5 articles.

1. HER2and Chromosome 17 Effect on Patient Outcome in the N9831 Adjuvant Trastuzumab Trial

2. Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer

3. Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

4. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

5. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concordance of HER2 status between core needle biopsy and surgical resection specimens of breast cancer: an analysis focusing on the HER2-low status;Breast Cancer;2024-04-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3